Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2417 | 2182 | 41.5 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1609 | 6531 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FC GAMMA RECEPTORS | Author keyword | 52 | 33% | 6% | 133 |
2 | FC RECEPTOR | Author keyword | 28 | 23% | 5% | 107 |
3 | FC GAMMA RIIA | Author keyword | 17 | 46% | 1% | 28 |
4 | FC RECEPTORS | Author keyword | 17 | 20% | 4% | 78 |
5 | FC GAMMA RIIB | Author keyword | 12 | 34% | 1% | 28 |
6 | FC GAMMA R | Author keyword | 10 | 27% | 1% | 31 |
7 | FC GAMMA RI | Author keyword | 9 | 38% | 1% | 19 |
8 | CD32 | Author keyword | 9 | 34% | 1% | 21 |
9 | FC GAMMA RIIIB | Author keyword | 9 | 52% | 1% | 12 |
10 | MOL GENET IMMUNOL | Address | 7 | 21% | 1% | 29 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FC GAMMA RECEPTORS | 52 | 33% | 6% | 133 | Search FC+GAMMA+RECEPTORS | Search FC+GAMMA+RECEPTORS |
2 | FC RECEPTOR | 28 | 23% | 5% | 107 | Search FC+RECEPTOR | Search FC+RECEPTOR |
3 | FC GAMMA RIIA | 17 | 46% | 1% | 28 | Search FC+GAMMA+RIIA | Search FC+GAMMA+RIIA |
4 | FC RECEPTORS | 17 | 20% | 4% | 78 | Search FC+RECEPTORS | Search FC+RECEPTORS |
5 | FC GAMMA RIIB | 12 | 34% | 1% | 28 | Search FC+GAMMA+RIIB | Search FC+GAMMA+RIIB |
6 | FC GAMMA R | 10 | 27% | 1% | 31 | Search FC+GAMMA+R | Search FC+GAMMA+R |
7 | FC GAMMA RI | 9 | 38% | 1% | 19 | Search FC+GAMMA+RI | Search FC+GAMMA+RI |
8 | CD32 | 9 | 34% | 1% | 21 | Search CD32 | Search CD32 |
9 | FC GAMMA RIIIB | 9 | 52% | 1% | 12 | Search FC+GAMMA+RIIIB | Search FC+GAMMA+RIIIB |
10 | CD64 | 6 | 21% | 1% | 26 | Search CD64 | Search CD64 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IIIB POLYMORPHISMS | 102 | 100% | 1% | 30 |
2 | CD32 | 42 | 66% | 2% | 39 |
3 | IGG FC | 40 | 46% | 3% | 65 |
4 | RIIA POLYMORPHISM | 38 | 89% | 1% | 17 |
5 | PROMOTER HAPLOTYPE | 38 | 78% | 1% | 25 |
6 | RECEPTOR III | 32 | 54% | 2% | 42 |
7 | RIII CD16 | 31 | 82% | 1% | 18 |
8 | EPSILON RI | 30 | 38% | 3% | 64 |
9 | CYTOPLASMIC DOMAIN HETEROGENEITY | 30 | 59% | 2% | 34 |
10 | FC GAMMA RIIIA 158F ALLELE | 28 | 81% | 1% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Fc gamma receptors as regulators of immune responses | 2008 | 752 | 123 | 48% |
Fc gamma receptors: Old friends and new family members | 2006 | 518 | 81 | 57% |
The function of Fc gamma receptors in dendritic cells and macrophages | 2014 | 47 | 147 | 33% |
Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all? | 2015 | 1 | 111 | 41% |
IgG Fc receptors | 2001 | 1008 | 95 | 55% |
HUMAN-IGG FC RECEPTOR HETEROGENEITY - MOLECULAR ASPECTS AND CLINICAL IMPLICATIONS | 1993 | 580 | 45 | 84% |
Properties of mouse and human IgG receptors and their contribution to disease models | 2012 | 101 | 98 | 40% |
Fc receptor biology | 1997 | 722 | 179 | 48% |
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications | 2010 | 130 | 161 | 51% |
FC-RECEPTORS | 1991 | 1233 | 129 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL GENET IMMUNOL | 7 | 21% | 1.3% | 29 |
2 | MEDAREX EUROPE | 6 | 35% | 0.6% | 14 |
3 | ANTICORPS THER IE PATHOL | 5 | 60% | 0.3% | 6 |
4 | IMMUNOL MEDAREX EUROPE | 4 | 75% | 0.1% | 3 |
5 | U760 | 3 | 27% | 0.5% | 11 |
6 | GENMAB | 2 | 30% | 0.3% | 6 |
7 | HELEN MACPHERSON SMITH TRUST INFLAMMATORY DIS | 2 | 50% | 0.1% | 3 |
8 | RHEUMATOL EXPT RHEUMATOL ADV THER EUT | 2 | 50% | 0.1% | 3 |
9 | EXPT IMMUNOL IMMUNOTHER Y | 2 | 29% | 0.3% | 6 |
10 | U255 | 2 | 12% | 0.6% | 13 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000113072 | COCUK NOROLOJISI BD//IMMUNOGLOBLIN//ALBUMIN DISTRIBUTION |
2 | 0.0000112647 | FC GAMMA RECEPTOR EXPRESSION//TRIANTHEMA PORTULACASTRUM//CELL BIOL INJURY SCI |
3 | 0.0000096976 | BIOL CELLULAIRE EXPT//ADHERING CELLS//EP 89 |
4 | 0.0000088519 | MULTIVALENT IMMUNOTOXINS//KINETIC PARAMETERS OF BINDING//CHRONIC LYMPHOLEUKEMIA |
5 | 0.0000080747 | SHIP2//INOSITOL 5 PHOSPHATASE//SHIP1 |
6 | 0.0000076514 | AGALACTOSYL IGG//PROT ANALYT CHEM//IGG GLYCOSYLATION |
7 | 0.0000073984 | FCRN//NEONATAL FC RECEPTOR//TARGET MEDIATED DRUG DISPOSITION |
8 | 0.0000071830 | LAIR 1//CD300A//FCRL |
9 | 0.0000068994 | CD20//OFATUMUMAB//OBINUTUZUMAB |
10 | 0.0000068317 | NEUTROPHIL SIGNALLING GRP//MOL SIGNALLING GRP//FFP 18 |